Abstract:OBJECTIVE:To search the role of Helicobacter pylori (H. pylori) in the progression of gastric carcinogenesis.METHODS:A cohort study was conducted by cluster randomized sampling in Linqu County, a rural area in Shandong Province in northeast China, where the mortality of gastric cancer (GC) is among the highest in the world. In 1989-1990, a gastroscopic examination and serum test was launched among subjects aged 35-64 from 14 randomized villages. Histological diagnosis of gastric mucosa and enzyme-linked immunosorbent assay was used to detect gastric lesions and anti-H. pylori of all participants. A repeated gastroscopic screening was offered to all cohort members in 1994 and 1999 respectively, and all the GC cases, regardless of natural ones or ones by gastroscopy, were registered in the follow-up periods.RESULTS:Fifty-eight cases of GC were identified in 2469 subjects during the 10-year follow-up, 44 were observed in 1603 H. pylori-positive persons (2.74%) and 14 in 866 H. pylori-negative persons (1.62%). The incidence rate of GC in H. pylori-positive is significantly higher than in H. pylori-negative (OR = 1.871, 95% CI: 1.012 - 3.459). There was no significant difference in the progression of gastric carcinogenesis between H. pylori-positive and H. pylori-negative (P > 0.05) among subjects with normal or superficial gastritis (SG) at baseline. In contrast, the significant difference was found in baseline chronic gastritis (CAG) group (P < 0.01), and the GC incidence rate in H. pylori-positive (7/615) is higher than in H. pylori-negative (0/470, P = 0.019). The difference of gastric lesions between H. pylori-positive and H. pylori-negative in subjects with intestinal metaplasia (IM) and dysplasia (DYS) at baseline was statistically significant after a 10-year follow-up (P < 0.05, P < 0.01, respectively), but the GC incidence rate in H. pylori-positive is similar to the rate in H. pylori-negative at the two groups (17/573 and 7/224 in IM group, P = 0.907; 19/368 and 7/122 in DYS group, P = 0.806).CONCLUSIONS:H. pylori is a key risk factor that prompts the transition from chronic atrophic gastritis to advanced precancerous lesions and influences the whole progression of precancerous gastric lesions. H. pylori, perhaps can not cause GC directly, increases the risk of GC in company with other carcinogens. H. pylori seemingly has no important effect on the development of GC when gastric mucosa is normal or superficial gastritis, but this conclusion is required to be further confirmed.

Increased 5-Hydroxymethylcytosine is a Favorable Prognostic Factor of Helicobacter Pylori-Negative Gastric Cancer Patients

Decreased 5-Hydroxymethylcytosine (5-Hmc) is an Independent Poor Prognostic Factor in Gastric Cancer Patients

Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma

Discovery and Validation of Novel Methylation Markers in Helicobacter Pylori-Associated Gastric Cancer

<i>Helicobacter pylori</i> associated aberrant methylation genes in blood leukocyte and gastric mucosa

Helicobacter pylori associated aberrant methylation genes in blood leukocyte and gastric mucosa

Global Changes of 5-Hydroxymethylcytosine and 5-Methylcytosine from Normal to Tumor Tissues Are Associated with Carcinogenesis and Prognosis in Colorectal Cancer

Higher Methylation Levels in Gastric Mucosae Significantly Correlate with Higher Risk of Gastric Cancers

Helicobacter pylori Infection, DNA Methylation, and Gastric Carcinogenesis

Positive H. pylori status predicts better prognosis of non-cardiac gastric cancer patients: results from cohort study and meta-analysis

Analysis of Key Genes and Signaling Pathways Involved in Helicobacter Pylori-Associated Gastric Cancer Based on the Cancer Genome Atlas Database and RNA Sequencing Data.

[Helicobacter Pylori and the Progression of Gastric Cancer: a 10-Year Cohort Study].

The Level and Clinical Significance of 5-Hydroxymethylcytosine in Oral Squamous Cell Carcinoma: an Immunohistochemical Study in 95 Patients.

Genome-wide DNA Methylation Profiles Altered by Helicobacter Pylori in Gastric Mucosa and Blood Leukocyte DNA

Analysis of the prognostic biomarkers associated with cancer stem cell characteristics and immune infiltration of Helicobacter pylori-induced gastric cancer

Hypermethylation Oftgf-Β1gene Promoter in Gastric Cancer

Low Level of 5-Hydroxymethylcytosine Predicts Poor Prognosis in Non-Small Cell Lung Cancer

The Prognostic Role of Helicobacter Pylori in Gastric Cancer Patients: A Meta-Analysis

DNA Hydroxymethylation of Colorectal Primary Carcinoma and Its Association with Survival.

Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.

Decreased 5-Hydroxymethylcytosine (5-Hmc) Predicts Poor Prognosis in Early-Stage Laryngeal Squamous Cell Carcinoma.